LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel...
esperityTM: the first multi-lingual online community for cancer patients worldwide
9/30/2013
esperityTM (www.esperity.com) announces its going live as the first multi-lingual social media network dedicated exclusively to cancer patients. esperityTM aims to support cancer patients around the world by providing them with an online environment where they can connect with each other and share information, thereby reducing the feeling of isolation many experience while dealing with cancer...
Commercial urine test for prostate cancer available
9/30/2013
A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs...
Novel tool developed by colorectal surgeons for measuring quality and outcomes
9/30/2013
Since the publication in 2000 of a report titled "To Err is Human" by the Institute of Medicine which called for a reduction in preventable medical errors, there has been an increasing demand for making improvements in the quality and measurement of health care outcomes...
The immunological function of mucus
9/30/2013
Researchers at Institut Hospital del Mar d'Investigacions Mediques (IMIM) in Barcelona, in collaboration with the Icahn School of Medicine at Mount Sinai in New York and other U.S. Institutions, have found that intestinal mucus not only acts as a physical barrier against commensal bacteria and dietary antigens, but also prevents the onset of inflammatory reactions against these agents...
Migrating cells, it seems, cover their tracks not for fear of being followed, but to keep moving forward. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now shown that cells in a zebrafish embryo determine which direction they move in by effectively erasing the path behind them...
Common patterns shared by different tumor types suggest new cancer treatment options
9/30/2013
Cancer encompasses a complex group of diseases traditionally defined by where in the body it originates, as in lung cancer or colon cancer. This framework for studying and treating cancer has made sense for generations, but molecular analysis now shows that cancers of different organs have many shared features, while cancers from the same organ or tissue are often quite distinct...
New research study of 'sister' stem cells uncovers cancer clue
9/30/2013
Scientists have used a brand new technique for examining individual stem cells to uncover dramatic differences in the gene expression levels - which genes are turned 'up' or 'down'- between apparently identical 'sister' pairs. The research, published in Stem Cell Reports, was conducted and funded by The Institute of Cancer Research, London...
Researchers explain for the first time the 'Jekyll-and-Hyde' nature of E2F in cancer
9/30/2013
The mood changes of a 'Jekyll-and-Hyde' protein, which sometimes boosts tumour cell growth and at other times suppresses it, have been explained in a new study led by Oxford University researchers. The researchers in Britain, with collaborators in Singapore and the USA, carried out a comprehensive biological study of the protein E2F, which is abnormal in the vast majority of cancers...
Critical regulator identified for directing pluripotent stem cells to make blood-forming stem cells
9/30/2013
Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online in Cell. The work was reported by Dr...